about
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients.Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II studySYT-SSX fusion genes and prognosis in synovial sarcoma.Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012.A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer.Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer.Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study.Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed.Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition.Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.The role of lymphadenectomy in cervical cancer patients: the significance of the number and the status of lymph nodes removed in 526 cases treated in a single institution.A prognostic model including pre- and postsurgical variables to enhance risk stratification of primary mediastinal nonseminomatous germ cell tumors: the 27-year experience of a referral center.Symptom interval in pediatric patients with solid tumors: adolescents are at greater risk of late diagnosis.Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancer.Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution.Erratum to: The nutritional risk in oncology: a study of 1,453 cancer outpatients.The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlates.Weight loss in cancer patients: a plea for a better awareness of the issue.Hope in cancer patients: the relational domain as a crucial factor.Secondary malignancies after high-dose chemotherapy in germ cell tumor patients: a 34-year retrospective study of the European Society for Blood and Marrow Transplantation (EBMT).Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center.A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.Intestinal type adenocarcinoma of the ethmoid sinus in wood and leather workers: a retrospective study of 153 cases.Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.Combination of paclitaxel, cisplatin, and gemcitabine (TPG) for multiple relapses or platinum-resistant germ cell tumors: long-term outcomes.Melanoma of the anorectal regionPostchemotherapy Lymphadenectomy in Patients With Metastatic Urothelial Carcinoma: Long-Term Efficacy and Implications for Trial DesignTreatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapyImatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical studyRole of Home Parenteral Nutrition in Chronic Radiation EnteritisExtremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution
P50
Q33273555-A13E5E9F-D57F-4150-927D-47724F189109Q33317905-E96F588A-5739-49F3-BF72-B58074CA0A1EQ34532365-874A11D4-31B6-4990-A5B1-5C44319D48F8Q34658767-6821FA7A-B4C1-4257-998F-C308B74D2031Q36609827-857AA2FD-E621-4CA4-B751-0D671B90D7A4Q36623165-A779A0ED-11EB-481D-8365-1BAB69A9FD89Q38390250-C119DFAB-DA8A-450D-A75B-CDF915254057Q39303051-9771CEAD-A3DC-4DB8-892C-32CF5E2498FBQ39573585-7B2325DB-898D-42F5-8850-7C54CED4DBD1Q40485928-BE6AE41E-A2BC-4558-8C11-4AAD89278245Q40756450-21FC1D23-C51A-4A18-8826-EB36D7C4F9E4Q40815142-09561A16-0333-4189-AA1F-066990AC137EQ40912134-B72A4341-3C8D-4452-836B-058DC34C4377Q40927886-0E53F7B5-3CCE-49B6-AABC-554AA23E5098Q40958255-3AC9A721-8468-42CB-90F6-7403B45B1711Q41371296-4B73AC38-1A8F-4F98-AC4A-05A71DD26012Q41393757-C18530C8-A364-4430-99D9-7A4470BDC1F8Q44276680-4CBC1003-35FA-4947-A017-6612A464461FQ44546909-AE60686E-4B7F-49DB-9D2D-CC80AE9D60CEQ44928349-62007A8C-4BEC-4E0D-B140-9A300148E584Q45070936-F53AB66E-B9E9-4D7C-A00C-C62F3F2C61E0Q45165301-0C04AED7-C77E-4F50-9C64-9B43D3DC4D78Q45257998-0BCA12E5-1B4E-428B-B8CB-605B4A42C7E5Q46447342-614872CB-F8CD-49C1-96D2-7AB84C5DEA83Q46626071-D2606D52-8674-4398-9311-31B23E85A18AQ47397575-1DD6339D-430E-45F6-902A-7D325F77A039Q47567757-289C2F8A-3FF5-4C2B-A551-DF96754B9C3AQ48171533-03A84BAD-8FDD-4BB2-A173-7552086FE11DQ48304341-0287CD24-0B11-4D46-AC85-A17EDD4DF003Q49821268-397D2647-4333-4308-8D36-C1E6CCEF7BAEQ51122492-1456B59C-FA8D-4495-90BF-BBFED660E11EQ53309839-79D2E04D-309A-4DD4-8CC4-13631625E357Q54301350-13E46091-88DF-49F6-A5BA-43F47762A55EQ54693710-9F5206D8-02BB-4282-8DB8-739C7356E4EAQ56656302-1ADF63EC-6A1A-4AAF-833D-B17A0B93C8C5Q57575092-0110A789-051E-4202-8B42-B62CD8B7A97FQ58199982-468AC030-CCB0-40CB-BA10-D9CEFA4CC03CQ59439756-B20B66C4-ADB7-4FA7-A0F6-48BCFA309B68Q61045907-E92A3562-89B4-4CEB-9034-4FB97004EB15Q61622949-C5A49CC5-0F3B-4D5F-AA47-FD3DEA32075B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Salvatore Lo Vullo
@ast
Salvatore Lo Vullo
@en
Salvatore Lo Vullo
@es
Salvatore Lo Vullo
@nl
Salvatore Lo Vullo
@sl
type
label
Salvatore Lo Vullo
@ast
Salvatore Lo Vullo
@en
Salvatore Lo Vullo
@es
Salvatore Lo Vullo
@nl
Salvatore Lo Vullo
@sl
prefLabel
Salvatore Lo Vullo
@ast
Salvatore Lo Vullo
@en
Salvatore Lo Vullo
@es
Salvatore Lo Vullo
@nl
Salvatore Lo Vullo
@sl
P106
P1153
6506036465
P21
P31
P496
0000-0002-4444-9526